30
May
2023
Assessment of the efficacy of your gene therapy in our facilities!
We are proud to announce that we have obtained a 5-year approval from the French Ministry of Education and Research to use genetically modified organisms of containment class 1.
Gene therapy with adeno-associated virus (AAV) has advanced in the last few years from promising results in animal models to >100 clinical trials.
We have now the possibility to assess the efficacy of your gene therapy in our facilities.
Should you want to test your AAV in our pain models do not hesitate to contact us.